| ■ 영문 제목 : Global Metastatic Melanoma Diagnostic Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K03870 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 서비스 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 전이성 흑색종 진단의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (BRAF 변이, 순환 종양 세포 (CTC), 면역 조직 화학, 기타)와 용도별 시장규모 (병리학 연구소, 병원, 암 연구 센터, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 전이성 흑색종 진단 시장 점유율 - 지역별 전이성 흑색종 진단 시장규모 - 주요지역의 종류별 시장규모 (BRAF 변이, 순환 종양 세포 (CTC), 면역 조직 화학, 기타) - 주요지역의 용도별 시장규모 (병리학 연구소, 병원, 암 연구 센터, 기타) - 미주의 전이성 흑색종 진단 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 전이성 흑색종 진단 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 전이성 흑색종 진단 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 전이성 흑색종 진단 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 전이성 흑색종 진단 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, Cancer Genetics, Castle Biosciences, NeoGenomics, Dermtech, Sysmex Inostics - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Metastatic Melanoma Diagnostic will have significant change from previous year. By the most conservative estimates of global Metastatic Melanoma Diagnostic market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Metastatic Melanoma Diagnostic market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Metastatic Melanoma Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
BRAF Mutation
Circulating Tumor Cells (CTCs)
Immunohistochemistry
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Pathology Laboratories
Hospitals
Cancer Research Centres
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Myriad Genetics
Abbott Laboratories
Foundation Medicine
Pathway Genomics Corporation
Cancer Genetics
Castle Biosciences
NeoGenomics
Dermtech
Sysmex Inostics
1 Scope of the Report 2 Executive Summary 3 Metastatic Melanoma Diagnostic Market Size by Players 4 Metastatic Melanoma Diagnostic by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Metastatic Melanoma Diagnostic Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Metastatic Melanoma Diagnostic Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of BRAF Mutation Table 3. Major Players of Circulating Tumor Cells (CTCs) Table 4. Major Players of Immunohistochemistry Table 5. Major Players of Others Table 6. Metastatic Melanoma Diagnostic Market Size CAGR by Type (2020-2026) & ($ Millions) Table 7. Global Metastatic Melanoma Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 8. Global Metastatic Melanoma Diagnostic Market Size Market Share by Type (2016-2021) Table 9. Metastatic Melanoma Diagnostic Market Size CAGR by Application (2016-2021) & ($ Millions) Table 10. Global Metastatic Melanoma Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 11. Global Metastatic Melanoma Diagnostic Market Size Market Share by Application (2016-2021) Table 12. Global Metastatic Melanoma Diagnostic Revenue by Players (2019-2021E) & ($ Millions) Table 13. Global Metastatic Melanoma Diagnostic Revenue Market Share by Players (2019-2021E) Table 14. Metastatic Melanoma Diagnostic Key Players Head office and Products Offered Table 15. Metastatic Melanoma Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Metastatic Melanoma Diagnostic Market Size by Regions 2016-2021 & ($ Millions) Table 19. Global Metastatic Melanoma Diagnostic Market Size Market Share by Regions 2016-2021 Table 20. Americas Metastatic Melanoma Diagnostic Market Size by Country (2016-2021) & ($ Millions) Table 21. Americas Metastatic Melanoma Diagnostic Market Size Market Share by Country (2016-2021) Table 22. Americas Metastatic Melanoma Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 23. Americas Metastatic Melanoma Diagnostic Market Size Market Share by Type (2016-2021) Table 24. Americas Metastatic Melanoma Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 25. Americas Metastatic Melanoma Diagnostic Market Size Market Share by Application (2016-2021) Table 26. APAC Metastatic Melanoma Diagnostic Market Size by Region (2016-2021) & ($ Millions) Table 27. APAC Metastatic Melanoma Diagnostic Market Size Market Share by Region (2016-2021) Table 28. APAC Metastatic Melanoma Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 29. APAC Metastatic Melanoma Diagnostic Market Size Market Share by Type (2016-2021) Table 30. APAC Metastatic Melanoma Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 31. APAC Metastatic Melanoma Diagnostic Market Size Market Share by Application (2016-2021) Table 32. Europe Metastatic Melanoma Diagnostic Market Size by Country (2016-2021) & ($ Millions) Table 33. Europe Metastatic Melanoma Diagnostic Market Size Market Share by Country (2016-2021) Table 34. Europe Metastatic Melanoma Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 35. Europe Metastatic Melanoma Diagnostic Market Size Market Share by Type (2016-2021) Table 36. Europe Metastatic Melanoma Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 37. Europe Metastatic Melanoma Diagnostic Market Size Market Share by Application (2016-2021) Table 38. Middle East & Africa Metastatic Melanoma Diagnostic Market Size by Region (2016-2021) & ($ Millions) Table 39. Middle East & Africa Metastatic Melanoma Diagnostic Market Size Market Share by Region (2016-2021) Table 40. Middle East & Africa Metastatic Melanoma Diagnostic Market Size by Type (2016-2021) & ($ Millions) Table 41. Middle East & Africa Metastatic Melanoma Diagnostic Market Size Market Share by Type (2016-2021) Table 42. Middle East & Africa Metastatic Melanoma Diagnostic Market Size by Application (2016-2021) & ($ Millions) Table 43. Middle East & Africa Metastatic Melanoma Diagnostic Market Size Market Share by Application (2016-2021) Table 44. Key and Potential Regions of Metastatic Melanoma Diagnostic Table 45. Key Application and Potential Industries of Metastatic Melanoma Diagnostic Table 46. Key Challenges of Metastatic Melanoma Diagnostic Table 47. Key Trends of Metastatic Melanoma Diagnostic Table 48. Global Metastatic Melanoma Diagnostic Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 49. Global Metastatic Melanoma Diagnostic Market Size Market Share Forecast by Regions (2021-2026) Table 50. Global Metastatic Melanoma Diagnostic Market Size Forecast by Type (2021-2026) & ($ Millions) Table 51. Global Metastatic Melanoma Diagnostic Market Size Market Share Forecast by Type (2021-2026) Table 52. Global Metastatic Melanoma Diagnostic Market Size Forecast by Application (2021-2026) & ($ Millions) Table 53. Global Metastatic Melanoma Diagnostic Market Size Market Share Forecast by Application (2021-2026) Table 54. Myriad Genetics Details, Company Type, Metastatic Melanoma Diagnostic Area Served and Its Competitors Table 55. Myriad Genetics Metastatic Melanoma Diagnostic Product Offered Table 56. Myriad Genetics Metastatic Melanoma Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 57. Myriad Genetics Main Business Table 58. Myriad Genetics Latest Developments Table 59. Abbott Laboratories Details, Company Type, Metastatic Melanoma Diagnostic Area Served and Its Competitors Table 60. Abbott Laboratories Metastatic Melanoma Diagnostic Product Offered Table 61. Abbott Laboratories Main Business Table 62. Abbott Laboratories Metastatic Melanoma Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 63. Abbott Laboratories Latest Developments Table 64. Foundation Medicine Details, Company Type, Metastatic Melanoma Diagnostic Area Served and Its Competitors Table 65. Foundation Medicine Metastatic Melanoma Diagnostic Product Offered Table 66. Foundation Medicine Main Business Table 67. Foundation Medicine Metastatic Melanoma Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 68. Foundation Medicine Latest Developments Table 69. Pathway Genomics Corporation Details, Company Type, Metastatic Melanoma Diagnostic Area Served and Its Competitors Table 70. Pathway Genomics Corporation Metastatic Melanoma Diagnostic Product Offered Table 71. Pathway Genomics Corporation Main Business Table 72. Pathway Genomics Corporation Metastatic Melanoma Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 73. Pathway Genomics Corporation Latest Developments Table 74. Cancer Genetics Details, Company Type, Metastatic Melanoma Diagnostic Area Served and Its Competitors Table 75. Cancer Genetics Metastatic Melanoma Diagnostic Product Offered Table 76. Cancer Genetics Main Business Table 77. Cancer Genetics Metastatic Melanoma Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 78. Cancer Genetics Latest Developments Table 79. Castle Biosciences Details, Company Type, Metastatic Melanoma Diagnostic Area Served and Its Competitors Table 80. Castle Biosciences Metastatic Melanoma Diagnostic Product Offered Table 81. Castle Biosciences Main Business Table 82. Castle Biosciences Metastatic Melanoma Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 83. Castle Biosciences Latest Developments Table 84. NeoGenomics Details, Company Type, Metastatic Melanoma Diagnostic Area Served and Its Competitors Table 85. NeoGenomics Metastatic Melanoma Diagnostic Product Offered Table 86. NeoGenomics Main Business Table 87. NeoGenomics Metastatic Melanoma Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 88. NeoGenomics Latest Developments Table 89. Dermtech Details, Company Type, Metastatic Melanoma Diagnostic Area Served and Its Competitors Table 90. Dermtech Metastatic Melanoma Diagnostic Product Offered Table 91. Dermtech Main Business Table 92. Dermtech Metastatic Melanoma Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 93. Dermtech Latest Developments Table 94. Sysmex Inostics Details, Company Type, Metastatic Melanoma Diagnostic Area Served and Its Competitors Table 95. Sysmex Inostics Metastatic Melanoma Diagnostic Product Offered Table 96. Sysmex Inostics Main Business Table 97. Sysmex Inostics Metastatic Melanoma Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 98. Sysmex Inostics Latest Developments List of Figures Figure 1. Metastatic Melanoma Diagnostic Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Metastatic Melanoma Diagnostic Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Metastatic Melanoma Diagnostic Market Size Market Share by Type in 2020 Figure 7. Metastatic Melanoma Diagnostic in Pathology Laboratories Figure 8. Global Metastatic Melanoma Diagnostic Market: Pathology Laboratories (2016-2021) & ($ Millions) Figure 9. Metastatic Melanoma Diagnostic in Hospitals Figure 10. Global Metastatic Melanoma Diagnostic Market: Hospitals (2016-2021) & ($ Millions) Figure 11. Metastatic Melanoma Diagnostic in Cancer Research Centres Figure 12. Global Metastatic Melanoma Diagnostic Market: Cancer Research Centres (2016-2021) & ($ Millions) Figure 13. Metastatic Melanoma Diagnostic in Others Figure 14. Global Metastatic Melanoma Diagnostic Market: Others (2016-2021) & ($ Millions) Figure 15. Global Metastatic Melanoma Diagnostic Market Size Market Share by Application in 2020 Figure 16. Global Metastatic Melanoma Diagnostic Revenue Market Share by Player in 2020 Figure 17. Global Metastatic Melanoma Diagnostic Market Size Market Share by Regions (2016-2021) Figure 18. Americas Metastatic Melanoma Diagnostic Market Size 2016-2021 ($ Millions) Figure 19. APAC Metastatic Melanoma Diagnostic Market Size 2016-2021 ($ Millions) Figure 20. Europe Metastatic Melanoma Diagnostic Market Size 2016-2021 ($ Millions) Figure 21. Middle East & Africa Metastatic Melanoma Diagnostic Market Size 2016-2021 ($ Millions) Figure 22. Americas Metastatic Melanoma Diagnostic Market Size Market Share by Country in 2020 Figure 23. Americas Metastatic Melanoma Diagnostic Market Size Market Share by Type in 2020 Figure 24. Americas Metastatic Melanoma Diagnostic Market Size Market Share by Application in 2020 Figure 25. United States Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 26. Canada Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 27. Mexico Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 28. APAC Metastatic Melanoma Diagnostic Market Size Market Share by Regions in 2020 Figure 29. APAC Metastatic Melanoma Diagnostic Market Size Market Share by Type in 2020 Figure 30. APAC Metastatic Melanoma Diagnostic Market Size Market Share by Application in 2020 Figure 31. China Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 32. Japan Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 33. Korea Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 34. Southeast Asia Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 35. India Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 36. Australia Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 37. Europe Metastatic Melanoma Diagnostic Market Size Market Share by Country in 2020 Figure 38. Europe Metastatic Melanoma Diagnostic Market Size Market Share by Type in 2020 Figure 39. Europe Metastatic Melanoma Diagnostic Market Size Market Share by Application in 2020 Figure 40. Germany Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 41. France Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 42. UK Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 43. Italy Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 44. Russia Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 45. Middle East & Africa Metastatic Melanoma Diagnostic Market Size Market Share by Region in 2020 Figure 46. Middle East & Africa Metastatic Melanoma Diagnostic Market Size Market Share by Type in 2020 Figure 47. Middle East & Africa Metastatic Melanoma Diagnostic Market Size Market Share by Application in 2020 Figure 48. Egypt Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 49. South Africa Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 50. Israel Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 51. Turkey Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 52. GCC Country Metastatic Melanoma Diagnostic Market Size Growth 2016-2021 ($ Millions) Figure 53. Americas Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 54. APAC Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 55. Europe Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 56. Middle East & Africa Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 57. United States Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 58. Canada Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 59. Mexico Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 60. Brazil Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 61. China Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 62. Japan Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 63. Korea Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 64. Southeast Asia Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 65. India Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 66. Australia Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 67. Germany Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 68. France Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 69. UK Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 70. Italy Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 71. Russia Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 72. Spain Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 73. Egypt Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 74. South Africa Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 75. Israel Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 76. Turkey Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) Figure 77. GCC Country Metastatic Melanoma Diagnostic Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 전이성 흑색종 진단 시장예측 2021년-2026년] (코드 : LPI-2201K03870) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 전이성 흑색종 진단 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |